1.Research Progress of TCM Etiology, Pathogenesis and Syndromes of Chronic Atrophic Gastrtis
Chinese Journal of Information on Traditional Chinese Medicine 2015;22(8):133-136
Chronic atrophic gastritis (CAG) is the disease with the pathological features of gastric mucosa inherent glands atrophy, mucous membrane thinning, muscularis mucosa thickening, gastric acid secretion decreasing, or along with intestinal metaplasia or pseudopyloric metaplasia. TCM differential treatment has obvious advantages. Through the summary of the literature on CAG, the authors summarize the aspects of etiology and pathogenesis, syndrome differentiation characteristic and their relations with gastroscopic image, pathology, and Helicobacter pylori infection, with a purpose to provide references for TCM clinic.
2.Application Analysis and Research of Patient Reported Outcome Instrument for Chronic Hepatitis Diseases
Huimin LIU ; Shaoneng LIU ; Zhen LIU
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(06):-
Objective To explore the reliability,validity and reaction degree of patient reported outcome instrument for chronic hepatitis diseases.Methods One hundred and four cases with chronic B hepatitis,chronic C hepatitis,alcoholic liver disease,steatohepatitis and decompensated cirrhosis were included and tested by patient reported outcome instrument for chronic hepatitis diseases and compared with 51 normal people.The reliability,validity and reaction degree were analyzed.The chronic hepatitis patient and normal people,chronic B hepatitis and other patients with liver disease were compared.Result The total Cronbach's Alpha of the instrument was 0.915,the total split-half reliability was 0.703,the KMO value was 0.783,Bartlett test value was 1 801.149(P 1,which contributed to 69.636%.The chronic hepatitis patients and normal people,chronic B Hepatitis patients and others were analyzed respectively by T test,P value were 0.000 and 0.413 respectively.Conclusion The instrument has a good internal reliability,validity and reaction degree,which can be applied for the therapeutic evaluation of chronic hepertatis diseases.
3.Research on Developing Law of Pathogeny and Mechanism of Chronic Hepatitis Type B
Shaoneng LIU ; Xiaping TAO ; Rongbin WANG
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(12):-
Objective To discuss the developing law of pathogeny and mechanism of chronic hepatitis type B.Methods Patients of chronic hepatitis type B,early hepatocirrhosis and ascites caused by hepatocirrhosis was chosen as objects and clinical information was collected face to face.Patterns of Chinese medicine were confirmed and counted seperately according to efficiency,deficiency and efficiency-deficiency sydrome,harmed Zang-Fu organs and syndrome factors.Finally,the developing law of pathogeny and mechanism was analyzed.Results As the state of chronic hepatitis type Bevolving,simple efficiency and deficiency sydrome decrease with efficiency-deficiency sydrome increasing.Zang-Fu organs damaged by chronic hepatitis type B including mostly liver,gallblader,spleen,stomach,kidney,Trijiao and so on,among which spleen and liver are mainly damaged.As the state of chronic hepatitis type B evolving,the frequencies of damage to gallblader,spleen,stomach,kidney,Trijiao and so on increase.Most simple chronic hepatitis type B cases are due to Shi,Shi-Re,efficiency and stasis of Qi,while most of early hepatocirrhosis stem from Shi-Re,extravasated blood,efficiency and stasis of Qi,with that of ascites caused by hepatocirrhosis originating from Shi-Re,extravasated blood,Shui,efficiency of Qi and Yin. Conclusion There is developing law in the character,location and syndrome factors of chronic hepatitis type B.
4.Effects of Qishu Granule on PI3K/Akt Signaling Transduction Pathways in the Process of Hepatic Fibrosis
Shaoneng LIU ; Qinggao YANG ; Peng PAN ; Xiaping TAO ; Huimin LIU
Chinese Journal of Information on Traditional Chinese Medicine 2014;(7):58-60,61
Objective To observe the effects of Qishu granule on PI3K/Akt signaling transduction pathways in the process of hepatic fibrosis, and further explain the anti-hepatic fibrosis mechanism of Qishu granule.Methods Wistar rats were randomly divided into normal group, model group, experimental control group and Qishu granule group. Liver fibrosis was duplicated in rats by intraperitoneal injection of CCl4, and the rats were given appropriate treatment at the same day. Rats in Qishu granule group were given a gavage 2 g/(kg?d), 1.0 mL/100 g, while rats in experimental control group and normal group were given the same amount of aquae sterilisata. Rats in each group were taken liver tissue samples in the 1st, 2nd and 4th week, and were checked for the protein expression levels of p-Akt (Ser473), p-Akt (Thr308), Bad (Ser136) and Caspase9 by Western blot.Results Compared with the model group, expression levels of p-Akt (Ser473), p-Akt (Thr308), Bad (Ser136) and Caspase9 in model and Qishu granule groups increased in every time points (P<0.05). Compared with the model group, expression level of p-Akt (Ser473) in Qishu granule group decreased significantly in the 1st, 2nd, and 4th weeks, expression level of Caspase9 dropped in the 1st and the 4th weeks, with statistical significance (P<0.05,P<0.01);expressions of p-Akt (Thr308) and Bad (Ser136) were lower than those in model group, without statistical significance (P>0.05).Conclusion Qishu granule could regulate PI3K/Akt signaling transduction pathways, and inhibit the occurrence and development of liver fibrosis.
5.Role of autophagy in liver fibrosis
Journal of Clinical Hepatology 2021;37(6):1440-1444
Autophagy refers to the process in which organelles and proteins in eukaryocytes are degraded in lysosomes and their degradation products are reused, and it plays an important role in cell proliferation, differentiation, and homeostasis. In recent years, the role of autophagy in liver fibrosis has attracted more and more attention, and intervention of autophagy may become a new method for the treatment of liver fibrosis. This article summarizes the process and function of autophagy and its role in liver fibrosis. These data reveal the complex mechanism of action of autophagy in liver fibrosis and point out the need to find more reliable and definite mechanisms and targets for autophagy intervention in the future, so as to provide new ways for the treatment of liver fibrosis.